Patients with systemic lupus erythematosus who are underweight have distinct disease characteristics

被引:0
|
作者
Kwon, Oh Chan [1 ]
Park, Min-Chan [1 ]
机构
[1] Yonsei Univ, Dept Internal Med, Div Rheumatol, Coll Med, Seoul, South Korea
关键词
Systemic lupus erythematosus; underweight; disease activity; QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; OBESITY; ADIPONECTIN; IMPACT; INFLAMMATION; LEPTIN; WOMEN; RISK;
D O I
10.1177/09612033231220726
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
<bold>Objective: </bold>This study aimed to detail the disease characteristics of systemic lupus erythematosus (SLE) in individuals who are underweight and assess whether underweight status is associated with SLE disease activity.<bold>Methods: </bold>This was a retrospective cohort study involving 218 patients newly diagnosed with SLE. Patients were categorized as underweight (body mass index [BMI] <18.5 kg/m(2)) or not underweight (BMI >= 18.5 kg/m(2)). We reviewed disease characteristics including the SLE Disease Activity Index 2000 (SLEDAI-2K) at diagnosis. High disease activity was defined as SLEDAI-2K >= 10. Disease characteristics were compared between those who were underweight and not underweight. We used multivariable logistic regression analysis to determine whether underweight status is associated with high disease activity.<bold>Results: </bold>Out of the 218 patients, 35 (16.1%) were underweight and 183 (83.9%) were not. Underweight patients had less renal involvement (5.7% vs 20.2%, p = .040), lower C-reactive protein levels (1.0 [0.3-2.3] mg/L vs 1.2 [0.8-5.0] mg/L, p = .028), and lower SLEDAI-2K scores (6.7 +/- 4.6 vs 9.1 +/- 5.7, p = .009), and were less likely to be at high disease activity status (22.9% vs 42.6%, p = .028), compared with those who were not underweight. Following adjustment for multiple covariates, being underweight was inversely associated with high disease activity status (adjusted odds ratio = 0.38, 95% confidence interval = 0.16 to 0.92, p = .031).<bold>Conclusion: </bold>Patients with SLE who were underweight showed less renal involvement and lower SLEDAI-2K scores compared with those who were not underweight. Moreover, those with SLE who were underweight had a 60% lower risk of exhibiting high disease activity.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 50 条
  • [1] THE CHARACTERISTICS OF SYSTEMIC LUPUS ERYTHEMATOSUS WHO HAVE CONSTITUTIONAL SYMPTOMS AND LYMPHADENOPATHY
    Erez, Y.
    Gulle, S.
    Karakas, A.
    Bekis, R.
    Balci, A.
    Birlik, M.
    Can, G.
    Onen, F.
    Sari, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 627 - 628
  • [2] Heart disease characteristics in patients with systemic lupus erythematosus
    Patino Giraldo, Santiago
    Gonzalez Naranjo, Luis Alonso
    Vasquez Duque, Gloria Maria
    Restrepo Escobar, Mauricio
    IATREIA, 2013, 26 (04) : 447 - U107
  • [3] Systemic lupus erythematosus patients have a distinct structural and functional skin microbiota compared with controls
    Zhou, Hao-Yue
    Cao, Nv-Wei
    Guo, Biao
    Chen, Wen-Jun
    Tao, Jin-Hui
    Chu, Xiu-Jie
    Meng, Xiang
    Zhang, Tian-Xiang
    Li, Bao-Zhu
    LUPUS, 2021, 30 (10) : 1553 - 1564
  • [4] Disease manifestations in patients with subacute cutaneous lupus erythematosus who meet criteria for systemic lupus
    Tiao, J.
    Werth, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S32 - S32
  • [5] Higher skin disease scores distinguish patients who progress from cutaneous lupus erythematosus to systemic lupus erythematosus
    Walocko, F.
    Anderson, S.
    Adams-Huet, B.
    Chong, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S96 - S96
  • [6] SYSTEMIC LUPUS ERYTHEMATOSUS - DISEASE IMPACT ON PATIENTS
    Macejova, Zelmira
    Zarikova, Michaela
    Oetterova, Maria
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2013, 21 (03) : 171 - 173
  • [7] Celiac disease in patients with systemic lupus erythematosus
    Soltani, Zahra
    Baghdadi, Azarakhsh
    Nejadhosseinian, Mohammad
    Faezi, Seyedeh Tahereh
    Shahbazkhani, Bijan
    Mousavi, Seyed Ali
    Kazemi, Kiarash
    REUMATOLOGIA, 2021, 59 (02): : 85 - 89
  • [8] 2 DISTINCT SUBSETS OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    MCINERNEY, MF
    CLOUGH, JD
    SENITZER, D
    CATHCART, MK
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 49 (01): : 116 - 132
  • [9] Retinal disease in patients with systemic lupus erythematosus
    Ushiyama, O
    Ushiyama, K
    Koarada, S
    Tada, Y
    Suzuki, N
    Ohta, A
    Oono, S
    Nagasawa, K
    ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (09) : 705 - 708
  • [10] Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease
    Cardiel, MH
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (01) : 77 - 88